HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Giurescu Selected Research

Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)

9/2017Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Giurescu Research Topics

Disease

3Neoplasms (Cancer)
09/2017 - 10/2009
2Ovarian Neoplasms (Ovarian Cancer)
01/2012 - 11/2011
1Lymphoma (Lymphomas)
09/2017
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2017
1Prostatic Neoplasms (Prostate Cancer)
08/2012
1Fatigue
11/2011
1Arthralgia (Joint Pain)
11/2011
1Nausea
11/2011

Drug/Important Bio-Agent (IBA)

5sagopiloneIBA
08/2012 - 10/2009
3Epothilones (Epothilone)IBA
08/2012 - 03/2010
2PlatinumIBA
01/2012 - 11/2011
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
09/2017
1copanlisibIBA
09/2017
1Prednisone (Sone)FDA LinkGeneric
08/2012
1Carboplatin (JM8)FDA LinkGeneric
01/2012
1Pharmaceutical PreparationsIBA
11/2011

Therapy/Procedure

1Castration
08/2012